🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Duopharma Biotech Berhad (KLSE:DPHARMA)
Malaysia flag Malaysia · Delayed Price · Currency is MYR
1.030
-0.050 (-4.63%)
At close: Nov 20, 2026

Duopharma Biotech Berhad Balance Sheet

Millions MYR. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
181.2290.87264.55270.5157.64137.98
Cash & Short-Term Investments
181.2290.87264.55270.5157.64137.98
Cash Growth
-32.56%9.95%-2.20%71.60%14.25%-12.69%
Accounts Receivable
243.22216.02184.33135.04131.31122.42
Other Receivables
5.616.6323.5926.3810.8410.31
Receivables
248.82232.65207.92161.42142.15132.72
Inventory
337.74293.17248.55243.07235.18222.19
Prepaid Expenses
-3.335.392.086.521.9
Total Current Assets
767.75820.02726.4677.07541.49494.8
Property, Plant & Equipment
542.36554.11567.52582.37579.92542.53
Long-Term Investments
14.4416.4822.6736.9142.1573.54
Other Intangible Assets
34.276.377.327.653.844.95
Long-Term Deferred Tax Assets
15.9922.6215.338.9513.3312.7
Long-Term Deferred Charges
-30.5237.5531.1540.1434.58
Other Long-Term Assets
1.051.051.051.051.051.05
Total Assets
1,3761,4511,3781,3451,2221,164

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
166.4453.9855.8940.4551.9331.32
Accrued Expenses
-83.446.9233.7940.4661.2
Short-Term Debt
-29.0932.3350.59101.887.85
Current Portion of Long-Term Debt
36.13118.3415.6614.9532.3415.08
Current Portion of Leases
-0.720.550.920.940.64
Current Income Taxes Payable
6.454.290.740.371.176.06
Other Current Liabilities
-25.1425.8925.6535.9528.17
Total Current Liabilities
209.02314.96177.99166.73264.59230.31
Long-Term Debt
332.15345.47464.52480.9294.6297.8
Long-Term Leases
2.42.472.761.481.922.48
Long-Term Deferred Tax Liabilities
31.1430.6423.428.915.589.54
Total Liabilities
574.71693.54668.68658.01566.7540.13

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
432.47432.47432.47432.47419.37405.86
Retained Earnings
453.36408.57354.78319.07288.37239.97
Comprehensive Income & Other
-84.68-83.41-78.09-64.41-52.52-21.82
Shareholders' Equity
801.14757.62709.15687.12655.22624
Total Liabilities & Equity
1,3761,4511,3781,3451,2221,164

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
370.68496.08515.82548.85431.6403.84
Net Cash (Debt)
-189.48-205.21-251.28-278.35-273.97-265.86
Net Cash Growth
------
Net Cash Per Share
-0.20-0.21-0.26-0.29-0.29-0.29
Filing Date Shares Outstanding
961.44961.94961.94961.94952.24941.77
Total Common Shares Outstanding
961.44961.94961.94961.94952.24941.77
Working Capital
558.73505.07548.42510.34276.9264.49
Book Value Per Share
0.830.790.740.710.690.66
Tangible Book Value
766.87751.26701.84679.47651.38619.06
Tangible Book Value Per Share
0.800.780.730.710.680.66
Land
-65.6865.6865.6869.8869.88
Buildings
-269.88267.09265.86125.23124.51
Machinery
-467.96452.39435.18368.47308.94
Construction In Progress
-14.5212.198.48172.65162.63